Topical Mydriatic and Cycloplegic Spray for Chinese Children

Journal of Pediatric Ophthalmology and Strabismus

Volumn 40, Issue 6, 2003, Pages 349-352

  Wong, Chun Yu ^a   Fan, Dorothy S P ^b   Yu, Christopher B O ^b   Lam, Dennis S C ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPENTOLATE; CYCLOPLEGIC AGENT; EYE DROPS; MYDRIATIC AGENT; PHENYLEPHRINE; TROPICAMIDE;

AEROSOL; ARTICLE; CHILD; CHINESE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MYDRIASIS; NORMAL HUMAN; PUPIL; RANK SUM TEST; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

EID: 0345357862     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: 10.3928/0191-3913-20031101-08     Document Type: Article

References (19)

1. Bujara K, Schulz E, Haase W. Retinoscopy under cycloplegic and non cycloplegic conditions in children: comparison of measurement of three examiners. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1981;216:339-343.
2. Hug T, Cibis GW, Lynd J. The use of spray topical drug delivery system for cycloplegic medications in children. Binocul Vis Strabismus Q 1997;12:191-194.
3. Wesson MD, Bartlett JD, Swiatocha J, Woolley T. Efficacy of a pediatric cycloplegic administered as a spray. Journal of the American Optometric Association 1993;64:617-621.
4. Wesson MD, Bartlett JD, Swiatocha J, Woolley T. Mydriatic efficacy of a cycloplegic spray in the pediatric population. Journal of the American Optometric Association 1993;64:637-640.
5. Lin LLK, Shih YF, Hsiao CH, Su TC, Chen CJ, Hung PT. The cycloplegic effects of cyclopentolate and tropicamide on myopic children. J Ocul Pharmacol Ther 1998;14:331-335.
6. Salazar M, Shimada K, Patil PN. Iris pigmentation and atropine mydriasis. J Pharmacol Exp Ther 1976;197:79-88.
7. Carpenter WT Jr. Precipitous mental deterioration following cycloplegia with 0.2 percent cyclopentolate HCl. Arch Ophthalmol 1967;78:445-447.
8. Kennerdell JS, Wucher FP. Cyclopentolate associated with two cases of grand mal seizure. Arch Ophthalmol 1972;87:634-635.
9. Awan KJ. Adverse systemic reactions of topical cyclopentolate hydrochloride. Ann J Ophthalmol 1976;8:695-698.
10. Binkhorst RD, Weinstein GW, Baretz RM, et al. Psychotic reaction induced by cyclopenrolate. Am J Ophthalmol 1963;55:1234-1245.
11. Beswick JA. Psychosis from cyclopentolate. Am J Ophthalmol 1962;53:879-880.
12. Isenberg SJ, Abrams C, Hyman PE. Effects of cyclopentolate eyedrops on gastric secretory function in pre-term infants. Ophthalmology 1985;92:698-700.
13. Palmer EA. How safe are ocular drugs in pediatrics? Ophthalmology 1986;93:1038-1040.
14. Isenberg S, Everett S, Parelhoff E. A comparison of mydriatic eyedrops in low-weight infants. Ophthalmology 1984;91:278-279.
15. Miranda MN. Residual accommodation: a comparison between cyclopentolare 1% and a combination of cyclopentolate 1% and tropicamide 1%. Arch Ophthalmol 1972;87:515-517.
16. Lovasik JV. Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide. Am J Optom Physiol Opt 1986;63:787-803.
17. Kleinstein RN, Mutti DO, Manny RE, Shin JA, Zadnik K. Cycloplegia in African-American children. Optom Vis Sci 1999;76:102-107.
18. Hiatt RL, Jerkins G. Comparison of atropine and tropicamide in esotropia. Ann Ophthalmol 1983;15:341-343.
19. Lin LLK, Shih YF, Hsiao CH, Su TC, Chen CJ, Hung PT. The cycloplegic effects of cyclopentolate and tropicamide on myopic children. J Ocul Pharmacol Ther 1998;14:331-335.